Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
Treatment of PNH hemolytic crisis with heparin or low-molecular weight heparin by its dual (anticomplement and anti-coagulant) activity
The anti-complement (C) activity of heparin has been well demonstrated, but its clinical use as anti-C drug has been limited by its anticoagulant activity. A 34-year-old man with PNH was complicated by two epi...